Back to search results

Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)

Abroad (travel likely)RecruitingPHASE2

Conditions

Lupus Nephritis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • State University of New York Upstate Medical Center (SUNY), Syracuse, New York, United States

  • Texas Transplant Institute, San Antonio, Texas, United States

  • University General Hospital ATTIKON, Athens, Greece

  • University General Hospital of Patras, Pátrai, Greece

  • Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom

    Study coordinator · UHBHaematologyResearchTeam@uhb.nhs.uk

  • Bristol Haematology and Oncology Centre, Bristol, United Kingdom

    Study coordinator · BHOCClinicalTrials@uhbw.nhs.uk

  • Addenbrooke's Hospital, Cambridge, United Kingdom

    Study coordinator · fatemeh.alemi@nhs.net

  • Western General Hospital Edinburgh, Edinburgh, United Kingdom

    Study coordinator · loth.rdoffice@nhs.scot

  • Queen Elizabeth University Hospital, Glasgow, United Kingdom

    Study coordinator · ggc.glasgowcrf.generic@nhs.scot

  • University College Hospital, London, United Kingdom

  • Great Ormond Street Hospital, London, United Kingdom

  • Manchester Royal Infirmary, Manchester, United Kingdom

View source on ClinicalTrials.gov(opens in a new tab)